Skip to main content
Clinical Trials/NCT02149069
NCT02149069UnknownNot Applicable

Blood Management Program: Appropriateness of Transfusion Therapy in the Post - Operative Period.

Arcispedale Santa Maria Nuova-IRCCS1 site in 1 country200 target enrollmentStarted: November 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
Evaluation of therapeutic appropriateness for Red Cells - Plasma - Platelets transfusion: comparison between prospective vs. retrospective data in ASMN ,Reggio Emilia (Italy)

Study Overview

Brief Summary

A care path in the field of transfusion medicine was creates at ASMN - IRCCS addressed to patients undergoing complex surgical procedures.

Detailed Description

This pathway is called Blood Management Program (BMP).

The implementation of this process should improve transfusion therapy in the peri-operative period in order to:

  • correct the transfusional approach to surgical patients
  • optimize the management of transfusional resources (red blood cells, plasma, platelets)
  • optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients undergoing complex surgical procedures

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Evaluation of therapeutic appropriateness for Red Cells - Plasma - Platelets transfusion: comparison between prospective vs. retrospective data in ASMN ,Reggio Emilia (Italy)

Time Frame: 24 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Arcispedale Santa Maria Nuova-IRCCS
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

PAMELABERNI

Data Manager

Arcispedale Santa Maria Nuova-IRCCS

Study Sites (1)

Loading locations...

Similar Trials